Journal profile · CHEMISTRY, MEDICINAL
Pharmacognosy Magazine
ISSN 0973-1296 · WOLTERS KLUWER MEDKNOW PUBLICATIONS · INDIA · Quarterly · Founded 2005
Pharmacognosy Magazine: CAS Zone 4 · Medicine (2025 upgraded edition); impact factor 0.99; fully open access; APC about USD 1,600; review about 3 months (community reports); community-reported acceptance: about 47.5%; 179 articles in 2025; indexed in SCIE.
Scope
Aims, scope and focus
Pharmacognosy Magazine is published by WOLTERS KLUWER MEDKNOW PUBLICATIONS and is in Zone 4 of Medicine in the CAS Journal Ranking (2025 upgraded edition). By OpenAlex counts of its recent articles, its largest topics are Natural product bioactivities and synthesis, Phytochemistry and Biological Activities and Phytochemicals and Antioxidant Activities, together about 23.9% of its articles. (generated from OpenAlex topic counts and CAS ranking data)
Pharmacognosy Magazine serves as a vital platform for researchers, academics, and practitioners in the field of natural product research.
From the journal's Aims & Scope
Research area (LetPub): CHEMISTRY, MEDICINAL
Main research topics OpenAlex counts of recent articles; shares are approximate
- Natural product bioactivities and synthesisBiochemistry, Genetics and Molecular Biology8.5%
- Phytochemistry and Biological ActivitiesAgricultural and Biological Sciences7.9%
- Phytochemicals and Antioxidant ActivitiesMedicine7.5%
- Natural Antidiabetic Agents StudiesMedicine7.5%
- Traditional Chinese Medicine AnalysisMedicine7.4%
- Essential Oils and Antimicrobial ActivityAgricultural and Biological Sciences6.7%
- Pharmacological Effects of Natural CompoundsPharmacology, Toxicology and Pharmaceutics5.9%
- Bioactive natural compoundsBiochemistry, Genetics and Molecular Biology4.2%
Rankings & indexing
CAS ranking and database indexing
CAS Journal Ranking
CAS Journal Ranking, upgraded edition (March 2025)Medicine Zone 4
| Level | Category | Zone |
|---|---|---|
| Major | Medicine | Zone 4 |
| Minor | Chemistry, Medicinal | Zone 4 |
Top journal: noReview journal: no
CAS Xinrui Journal Ranking (March 2026)Medicine Zone 4
| Level | Category | Zone |
|---|---|---|
| Major | Medicine | Zone 4 |
| Minor | Chemistry, Medicinal | Zone 4 |
Top journal: noReview journal: not marked
CAS Journal Ranking, previous upgraded edition (December 2023)Medicine Zone 4
| Level | Category | Zone |
|---|---|---|
| Major | Medicine | Zone 4 |
| Minor | Chemistry, Medicinal | Zone 4 |
Top journal: noReview journal: no
Database indexing
SCIELetPub
International journal early-warning lists: not listed in any editionLetPub
Indexing the journal's website claims
Web of ScienceEmbasePublisher website
Other: CNKI, Google Scholar
As the journal's website lists them, not checked against each database; for Web of Science editions the records above apply.
Editions, and major and minor categories, are shown separately and never merged into one zone; check which edition your institution uses before you submit or report.
Metrics
Impact metrics and publication volume
Impact
- Impact factor
- 0.99LetPub ·
- CiteScore 2026-06
- 1.87LetPub ·
- SJR 2026-06
- 0LetPub ·
- SNIP 2026-06
- 0LetPub ·
- h-index
- 29LetPub ·
- h-index
- 65OpenAlex ·
- i10-index
- 1,023OpenAlex ·
- 2-year mean citedness
- 0.85OpenAlex ·
- Self-citation rate
- 0%LetPub ·
- Share of gold OA articles
- 97.51%LetPub ·
Volume
- Articles per year
- 178LetPub ·
Articles by year OpenAlex count · 2,490 in total · the current year is incomplete
| Year | Articles | Open access | Citations |
|---|---|---|---|
| 2026 | 67 | 67 | 3 |
| 2025 | 179 | 179 | 85 |
| 2024 | 166 | 166 | 264 |
| 2023 | 132 | 132 | 525 |
| 2022 | 46 | 15 | 172 |
| 2021 | 148 | 8 | 546 |
Sources count differently and were observed at different times, so each source's own value is kept; "publisher" marks figures from the journal's website.
Review & acceptance
Review time and acceptance
- Average review time (community reports)
- about 3 monthsLetPub ·
- Average acceptance (community reports)
- 47.5%LetPub ·
Community reports come from authors' own submissions (confidence 0.5) and are not a promise from the journal; for publisher figures, the journal's own definitions apply.
Fees & open access
APC and open-access policy
Fully open accessLetPub
Every article is open access; authors usually pay an article processing charge (APC).
| Source | APC | Fee waiver | License | Observed |
|---|---|---|---|---|
| OpenAlex | USD 1,600 | — | — |
The journal's website is authoritative for fees; sources were observed at different times and each keeps its own value, without averaging.
Submission
Article types and submission policies (journal website)
Article types accepted4
- case study• Original Research Articles • Review Articles • Short Communications • Case StudiesLength not stated
- original research article• Original Research Articles • Review Articles • Short Communications • Case StudiesLength not stated
- review article• Original Research Articles • Review Articles • Short Communications • Case StudiesLength not stated
- short communication• Original Research Articles • Review Articles • Short Communications • Case StudiesLength not stated
Policy excerpts from the journal's websiteOpen access, Peer review
- Open access Open Access
Committed to disseminating knowledge widely through open access publishing, available via Sage Journals platform.
Source ↗Publisher website ·- Peer review Peer Review
Rigorous peer-review process ensuring the highest standards of scientific integrity and methodological rigor.
Source ↗Publisher website ·
Excerpts are quoted from the journal's website; "model summary" lines are written by Workers AI and checked against the text. The journal's website is authoritative.
Profile
Publication details and official links
- Publisher
- WOLTERS KLUWER MEDKNOW PUBLICATIONS
- Country or region
- INDIA
- Language
- English
- Frequency
- Quarterly
- Founded
- 2005
- ISSN
- 0973-1296
- Official links
- Journal homepage ↗LetPub
FAQ
Frequently asked questions about Pharmacognosy Magazine
What CAS zone is Pharmacognosy Magazine in?
In the 2025 upgraded edition of the CAS Journal Ranking, Pharmacognosy Magazine is in Zone 4 of Medicine, and in Zone 4 of the minor category Chemistry, Medicinal. In the 2026 Xinrui edition it is in Zone 4 of Medicine. Zones from different editions, and from major and minor categories, are not interchangeable.
What is the impact factor of Pharmacognosy Magazine?
The latest impact factor listed by LetPub is 0.99; CiteScore 1.87, h-index 65.
How long does peer review take at Pharmacognosy Magazine?
Authors report an average review time of about 3 months; the community-reported acceptance is “about 47.5%”. Article statistics cover accepted papers only, publisher figures follow the journal's own definitions, and community reports come from authors' own submissions; none is a promise from the journal.
Which databases index Pharmacognosy Magazine?
According to LetPub and DOAJ records, Pharmacognosy Magazine is indexed in SCIE. The journal's website also lists Web of Science and Embase; that list has not been checked against each database.
Is Pharmacognosy Magazine open access, and what is the APC?
Pharmacognosy Magazine is a fully open-access journal. APC about USD 1,600.
Sources and updates
The facts on this page come from LetPub, OpenAlex, Publisher website; every figure is tagged with its source and the date it was observed, and conflicting values are kept per source. LetPub source page: view ↗ (archived 2026-08-24). Last updated: .